BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8697986)

  • 1. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p53 gene mutations in primary nasopharyngeal carcinomas.
    Spruck CH; Tsai YC; Huang DP; Yang AS; Rideout WM; Gonzalez-Zulueta M; Choi P; Lo KW; Yu MC; Jones PA
    Cancer Res; 1992 Sep; 52(17):4787-90. PubMed ID: 1511442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
    Van Tornout JM; Spruck CH; Shibata A; Schmutte C; Gonzalez-Zulueta M; Nichols PW; Chandrasoma PT; Yu MC; Jones PA
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):493-7. PubMed ID: 9232335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy.
    Chang KP; Hao SP; Lin SY; Tsao KC; Kuo TT; Tsai MH; Tseng CK; Tsang NM
    Laryngoscope; 2002 Nov; 112(11):2015-9. PubMed ID: 12439172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations.
    Sun Y; Hegamyer G; Colburn NH
    Oncogene; 1993 Mar; 8(3):791-5. PubMed ID: 8437863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of p53 and RB2/p130 genes in Malaysian nasopharyngeal carcinoma samples: a preliminary report.
    Hoe SL; Sam CK
    Malays J Pathol; 2006 Jun; 28(1):35-9. PubMed ID: 17694957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
    Sun Y; Hegamyer G; Cheng YJ; Hildesheim A; Chen JY; Chen IH; Cao Y; Yao KT; Colburn NH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6516-20. PubMed ID: 1631151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 abnormalities in endoscopic gastric biopsies.
    Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
    Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of p53 mutation using PCR-SSCP silver staining method].
    Zhao W; Si J; Li K; Zhang X; Song G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 oncoprotein expression and gene mutations in some keratoacanthomas.
    Perez MI; Robins P; Biria S; Roco J; Siegel E; Pellicer A
    Arch Dermatol; 1997 Feb; 133(2):189-93. PubMed ID: 9041832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia.
    Chakrani F; Armand JP; Lenoir G; Ju LY; Liang JP; May E; May P
    Int J Cancer; 1995 May; 61(3):316-20. PubMed ID: 7729941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.